ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.

J Clin Oncol · 2024 · PMC11095894 · PMID 38335473

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an obvious trendno p-value reported

No patients with two or more target lesions had a response by RANO-HGG criteria to ONC201 treatment (0 of 9) although neither multifocal disease nor overall tumor size demonstrated an obvious trend with objective response.

also in 287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.